CClinicalTrials.gg
Status unknownNCT05553106Updated Oct 21, 2022

Evaluation of Cognitive Status, Kinesiophobia, Physical Activity Level, and Functional Performance in Coronary Intensive Care

An observational study in Heart Diseases, sponsored by Hacettepe University. Status unknown at 1 site in Turkey. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2022-10-21.

Sponsored by Hacettepe University · Observational

The sponsor has not verified this record recently (last verified Oct 2022), so the status shown — last known as Active, not recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
10
Ages
18 Years to 75 Years
Sex
All
01

Study summary

The aim of our study is to evaluate cognitive status, kinesiophobia, physical activity level, and functional performance in coronary intensive care.

Read the detailed description

This study will be performed on patients who are hospitalized in the coronary intensive care unit, who can take simple commands, and whose condition is physiologically stable.

02

Conditions studied

  • Heart Diseases

Keywords

  • intensive care
  • coronary artery disease
  • kinesiophobia
  • physical activity level
03

In context

Heart Diseases

3,639 studies on the registry are indexed under Heart Diseases; 461 are open to participants now.

This study's planned enrollment of 10 is below the median of 294 across 1,241 observational studies indexed under Heart Diseases.

Browse Heart Diseases studies →

Lead sponsor

Hacettepe University is the lead sponsor of 983 studies on the registry; 212 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients in coronary intensive care unit who can take simple commands and whose condition is physiologically stable

Inclusion criteria

  • Volunteering to participate in the research
  • Being under surveillance in the coronary intensive care unit

Exclusion criteria

Exclusion Criteria:

  • Presence of neurological disease that may affect the cognitive status
  • Not being clinically stable
  • Not to cooperate
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
10 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Study Group

    Patients who are hospitalized in the coronary intensive care unit, who can take simple commands, and whose condition is physiologically stable.

06

What researchers measure

Primary outcomes

  1. Functional Performance Assessment

    Functional status score for the intensive care unit (FSS-ICU) will be used.

    Time frame: 2 weeks

Secondary outcomes

  1. Symptom Assessment

    Cardiac symptom survey will be used.

    Time frame: 2 weeks

  2. Cognitive Status Assessment

    The Montreal Cognitive Assessment (MoCA) will be used

    Time frame: 2 weeks

  3. Physical Activity Level

    Physical activity level will be evaluated using the International Physical Activity Questionnaire - Short Form (IPAQ-SF).

    Time frame: 2 weeks

  4. Fear of Movement

    Fear of movement will be evaluated using the Fear of Activity in Patients with Coronary Artery Disease (Fact-CAD).

    Time frame: 2 weeks

07

Study locations

1 site
  • Hacettepe University
    Ankara, Turkey
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 21, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05553106
Lead sponsor
Hacettepe University
Responsible party
Dilara Saklica (Principal Investigator, Hacettepe University) — Principal investigator
First posted
Sep 23, 2022
Start date
Sep 23, 2022
Primary completion
Nov 2022 (estimated)
Completion
Nov 2022 (estimated)
Last update
Oct 21, 2022

Study contacts

Naciye Vardar-Yagli, PhD
study director · Hacettepe University
Hikmet Yorgun, PhD
study director · Hacettepe University
Ahmet Hakan Ates, PhD
study chair · Hacettepe University
Dilara Saklica, MSc
principal investigator · Hacettepe University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion